443 related articles for article (PubMed ID: 26548749)
1. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
3. Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women.
Pandey S; Mittal RD; Srivastava M; Srivastava K; Singh S; Srivastava S; Mittal B
Gynecol Oncol; 2009 Sep; 114(3):501-5. PubMed ID: 19541348
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.
Pandey S; Mittal B; Srivastava M; Singh S; Srivastava K; Lal P; Mittal RD
Mol Biol Rep; 2011 Oct; 38(7):4715-21. PubMed ID: 21132533
[TBL] [Abstract][Full Text] [Related]
5. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.
Mandal RK; George GP; Mittal RD
Mol Biol Rep; 2012 Jul; 39(7):7263-9. PubMed ID: 22311043
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development.
Theodoropoulos GE; Saridakis V; Karantanos T; Michalopoulos NV; Zagouri F; Kontogianni P; Lymperi M; Gazouli M; Zografos GC
Breast; 2012 Aug; 21(4):534-8. PubMed ID: 22560646
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women.
Wujcicka W; Paradowska E; Studzińska M; Wilczyński J; Nowakowska D
Virol J; 2017 Mar; 14(1):64. PubMed ID: 28340580
[TBL] [Abstract][Full Text] [Related]
8. Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer.
Etokebe GE; Knezević J; Petricević B; Pavelić J; Vrbanec D; Dembić Z
Genet Test Mol Biomarkers; 2009 Dec; 13(6):729-34. PubMed ID: 19810822
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism ARG753GLN of TLR-2, LEU412PHE of TLR-3, ASP299GLY of TLR-4 in patients with influenza and influenza-associated pneumonia.
Pryimenko NO; Kotelevska TM; Koval TI; Syzova LM; Dubynska HM; Kaidashev IР
Wiad Lek; 2019; 72(12 cz 1):2324-2328. PubMed ID: 32124747
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.
Messaritakis I; Stogiannitsi M; Koulouridi A; Sfakianaki M; Voutsina A; Sotiriou A; Athanasakis E; Xynos E; Mavroudis D; Tzardi M; Souglakos J
PLoS One; 2018; 13(6):e0197327. PubMed ID: 29883450
[TBL] [Abstract][Full Text] [Related]
11. The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.
Yang S; Liu L; Xu D; Li X
Pathol Oncol Res; 2020 Jan; 26(1):307-315. PubMed ID: 30215163
[TBL] [Abstract][Full Text] [Related]
12. Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.
Jin Y; Qiu S; Shao N; Zheng J
Mamm Genome; 2017 Jun; 28(5-6):213-219. PubMed ID: 28497211
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors TLR4 (Asp299Gly and Thr399Ile) and TLR2 (Arg677Trp and Arg753Gln) gene polymorphisms in end-stage renal disease patients on peritoneal dialysis.
Singh K; Prasad KN; Mishra P; Khatoon J; Prasad N; Gupta A; Srivastava JK
Int Urol Nephrol; 2015 Dec; 47(12):2031-7. PubMed ID: 26490558
[TBL] [Abstract][Full Text] [Related]
14. Toll-like-receptor gene polymorphisms in a Tunisian population with Behçet's disease.
Ben Dhifallah I; Lachheb J; Houman H; Hamzaoui K
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S58-62. PubMed ID: 19796535
[TBL] [Abstract][Full Text] [Related]
15. Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) in Acute Myeloid Leukemia Patients.
Aref S; Abd Elmaksoud ASM; Abd Elaziz S; Mabed M; Ayed M
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3177-3183. PubMed ID: 33247673
[TBL] [Abstract][Full Text] [Related]
16. TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.
Proença MA; de Oliveira JG; Cadamuro AC; Succi M; Netinho JG; Goloni-Bertolo EM; Pavarino ÉC; Silva AE
World J Gastroenterol; 2015 Jul; 21(25):7730-41. PubMed ID: 26167073
[TBL] [Abstract][Full Text] [Related]
17. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
Pandey NO; Chauhan AV; Raithatha NS; Patel PK; Khandelwal R; Desai AN; Choxi Y; Kapadia RS; Jain ND
Sci Rep; 2019 Jul; 9(1):9729. PubMed ID: 31278284
[TBL] [Abstract][Full Text] [Related]
18. Association studies of Toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of North India.
Srivastava P; Singh A; Kesarwani P; Jaiswal PK; Singh V; Mittal RD
Clin Transplant; 2012; 26(4):581-8. PubMed ID: 22251233
[TBL] [Abstract][Full Text] [Related]
19. Gene Polymorphisms of Toll-Like Receptor 9 -1486T/C and 2848G/A in Cervical Cancer Risk.
Mu X; Zhao J; Yuan X; Zhao X; Yao K; Liu Y; Zhao X
Int J Gynecol Cancer; 2015 Sep; 25(7):1173-8. PubMed ID: 26270118
[TBL] [Abstract][Full Text] [Related]
20. Toll-like-Receptor Gene Polymorphisms in Tunisian Endemic Pemphigus Foliaceus.
Abida O; Bahloul E; Elloumi N; Toumi A; Tahri S; Ben Jmaa M; Fakhfakh R; Mahfoudh N; Turki H; Masmoudi H
Biomed Res Int; 2020; 2020():6541761. PubMed ID: 33204706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]